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V(D)J recombination is thought to be regulated by changes in the
accessibility of target sites, such as modulation of methylation. To
test whether demethylation of the kappa locus can activate re-
combination, we generated two recombinationally active B cell
lines in which the gene for maintenance of genomic DNA methyl-
ation, Dnmt1, was flanked with loxP sites. Transduction with a
retrovirus expressing both the cre recombinase and green fluores-
cent protein allowed us to purify recombinationally active cells
devoid of methylation. Loss of methylation of the kappa locus was
not sufficient to activate recombination, although transcription
was activated in one line. It appears that demethylation of the
kappa locus is not the rate-limiting step for altering accessibility
and thus regulated demethylation does not generate specificity of
recombination.
The V(D)J recombination machinery assembles antigen re-ceptor genes during lymphoid development from gene seg-
ments flanked by recombination signal sequences (1). This
nonhomologous site-specific recombination process is precisely
controlled by a number of different regulatory mechanisms. For
one thing, the coexpression of the lymphoid-specific Rag-1 and
Rag-2 genes occurs restrictively in developing B and T cells,
ensuring that only the appropriate cell types are recombination-
ally active (2). A second level of regulation also controls lineage
specificity: complete Ig gene rearrangement occurs only in B
cells, whereas T cell receptor genes rearrange exclusively in T
cells (3). Moreover, within developing B and T cells there are
temporal controls over specific gene segment usage (4, 5).
Additionally, allelic exclusion ensures that each B or T cell
generates only one functional antigen receptor even though two
alleles exist at each locus (6).
This remarkable ability of the recombination machinery to
target only a very small subset of substrates within a given cell
together with the fact that a single recombinase is required for
this process has led to the hypothesis that the accessibility of
DNA targets to the recombination machinery is tightly con-
trolled (7–9). Recombination loci are thought to be inaccessible
until they are modified to allow the recombination machinery
access to target sites. Changes in chromatin structure, transcrip-
tional activity, or DNA methylation at each locus have been
identified that correlate with recombinational activity. Many
studies have attempted to define the cis-acting sequences and
trans-acting factors required to regulate this process. Distinct
enhancer sequences present within individual loci must be
controlled by different trans-acting proteins to allow develop-
mentally regulated changes in the accessibility of each locus to
occur.
DNA methylation has been shown to regulate chromatin
structure, leading to changes of gene expression (10). Addition-
ally, methylation has been correlated with Ig gene regulation:
both the m heavy chain and k light chain are hypermethylated in
cells in which they are not recombined (11, 12). Concomitant
with V(D)J rearrangement these loci become hypomethylated
and transcriptionally active (13, 14). Regulated demethylation
could control the specificity of the V(D)J recombinase. Consis-
tent with such a concept, exogenously introduced hypermethy-
lated recombination substrates including both episomes and
transgenes are refractory to V(D)J recombination compared
with their unmethylated counterparts (15–17). At a minimum,
this suggests that methylation of target sites bound by ubiquitous
trans-acting factors inhibits recombination so that demethylation
of these loci should be required for the initiation of
recombination.
We sought to directly test whether demethylation of an
endogenous V(D)J target was sufficient to increase accessibility
for recombination. If demethylation was the rate limiting step
controlling the specificity of recombination, then forced demeth-
ylation should activate recombination of the unmethylated loci.
To this end, we established a model system to examine the
regulation of kappa recombination as a function of methylation
status by using Abelson virus-transformed cell lines that were
conditionally mutant for global DNA methylation. In these
Abelson lines, the gene encoding the maintenance DNA meth-
yltransferase, Dnmt1, was flanked by loxP sites allowing the
excision and loss of function of the gene when the cre recom-
binase was provided. Using this inducible system, we were able
to efficiently demethylate the kappa locus. However, this did not
activate recombination. In contrast, the loss of methylation did
activate transcription within the kappa locus of one of the
Abelson lines. Our results suggest that demethylation of the
kappa locus is not sufficient to activate V(D)J recombination,
thus supporting a model whereby specific factors must be
recruited to the locus to alter its accessibility for recombination
independent of other properties such as transcription or
methylation.
Materials and Methods
Cell Lines and Culture. Bone marrow-derived Abelson lines from
1-month-old Dnmt2loxyDnmtN mice (mice will be described
elsewhere) were established by conventional methods (18). The
v-abl retrovirus used to infect bone marrow cultures was pro-
duced from a helper free retroviral packaging system (19) by
using the construct pGD-v-abl (20). Abelson lines were main-
tained in RPMI (GIBCOyBRL) plus 10% defined FCS (Hy-
Clone), 50 mM b-mercaptoethanol (Sigma), and PenyStrep
(GIBCOyBRL). The 293 cells and derivatives were maintained
in DMEM (GIBCOyBRL) plus 10% FCS (JRH Biosciences,
Lenexa, KS) and PenyStrep. Lipopolysaccharide (LPS) (Sigma)
at 10 mgyml was added to cells 24 h before collection. Cells were
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pelleted and resuspended in media at 107 cellsyml, sorted for live
green fluorescent protein (Gfp)1 or Gfp2 cells, by using a
FACStar with Turbo cell sorter, and used immediately for
analysis.
Retroviral Infections and Constructs. MCiGfp was generated by
inserting a Cre-SV40 nuclear localization signal fusion protein
(21) into the multiple cloning site of MiGfp (22). The nonrep-
lication competent helper plasmid pCL-eco was a gift from Inder
Verma, The Salk Institute, San Diego. DNA was introduced into
293 cells by coprecipitation with calcium phosphate as described
(19). The viral supernatants were used for spin infections (22)
after which the viral supernatant was removed and replaced with
media (day 0 postinfection).
Southern Analysis. Cell pellets were washed once in PBS and then
lysed in DNA lysis buffer plus proteinase K at 55°C overnight as
described. The DNA then was phenolychloroform-extracted,
precipitated, and resuspended in TE-1 (10 mM Tris, pH 8.0y1
mM EDTA). Five micrograms of DNA was digested with the
appropriate restriction enzymes and loaded on an agarose gel.
The DNA was transferred to Nylon N (Hybond) and probed with
random primed (Stratagene) fragments: intracisternal A-type
particle (IAP) [nucleotides 1527–1690, 1712–1802, 1946–2160
from the mouse ren-2 IAP genome (23) assembled as a contig;
gift from D. Humphreys, Whitehead Institute, Cambridge, MA]
and CJk (24).
Recombination Assays. One hundred nanograms of genomic DNA
generated as above was used as a template for PCR. VJk PCR
fragments were amplified by using the primers Vk and Jk2 for 26
cycles consisting of 1 min 94°C, 1 min at 60°C, and 1.75 min at
72°C. The final polymerization step was extended an additional
10 min, and the PCR products were detected by Southern
analysis using the oligonucleotide Jk1 (25).
Reverse Transcription–PCR (RT-PCR) Analysis. Total cellular RNA
was purified from cultured cells with Trireagent (MRC, Cincin-
nati), DNase (Stratagene)-treated, phenolychloroform-
extracted, and precipitated. A total of 1 mg RNA was subjected
to RT using Moloney murine leukemia virus reverse transcrip-
tase (Boehringer Mannheim) and random primers. The reaction
was subjected to PCR analysis as described by using the primers
ko and Ck (26). The amplified products were subjected to
electrophoresis on an agarose gel, transferred to a nylon mem-
brane, and probed with Jk2 (27).
Results
Assay System. We generated Abelson virus transformed pre-B
cell lines to study the role of methylation in the regulation of
V(D)J recombination (18). Abelson lines were used because they
have been extensively characterized and used as a model system
for the regulation of early B cell development. Abelson lines are
recombinationally active and recombine their Ig loci in the same
developmentally ordered program of gene segment usage as
normal B cells. Abelson lines are typically D to JH rearranged on
both alleles and are actively rearranging their V regions to the
DJH segments. The level of recombination at the kappa locus is
very low. However, recombination can be induced by treatments
that alter the accessibility of the locus, allowing the retargeting
of the recombinase from the heavy chain to the kappa locus. For
example, treatment of Abelson lines with bacterial LPS activates
both transcription and recombination of kappa. Therefore, we
reasoned that Abelson lines would be a good model system to test
the role of methylation in V(D)J recombination of the kappa
locus.
Mice deficient for the gene that encodes the maintenance
DNA methyltransferase, Dnmt1, which remethylates the hemi-
methylated cytidines within CpG dinucleotides generated as a
product of DNA replication, die early in embryonic life. This
precludes analysis of how alterations in the methylation status of
recombination loci affect lymphoid development. Therefore, we
generated cell lines from mice that were conditionally mutant for
the Dnmt1 locus; one allele was null for the Dnmt1 gene (N
allele, ref. 28) whereas the other allele contained lox P sites
flanking exons required for the function of the gene (2lox, mice
will be described elsewhere). Abelson lines derived from these
animals are conditionally mutant for the Dnmt1 locus; upon
introduction of the cre recombinase, the allele containing the lox
P sites is excised, generating cells in which both alleles of the
Dnmt1 gene are mutant. We generated two independent Abel-
son lines of the genotype Dnmt2lox/N (Dnmtcond1, Dnmtcond2) and
assayed their rearrangement status. Southern blot analysis of
these lines demonstrated that the heavy chain had DJH rear-
rangements, whereas the kappa locus was in a germ-line con-
figuration (data not shown).
To introduce the cre recombinase efficiently into the Dnmtcond
lines we used a replication incompetent retroviral construct
containing the mouse stem cell virus long terminal repeat
(MSCV LTR) driving the expression of Gfp as a reporter for
infection (Fig. 1A; ref. 22). This retroviral vector contained a
multiple cloning site (MCS) upstream of an internal ribosomal
entry site (IRES) that allowed for enhanced Gfp expression
Fig. 1. Abelson lines are efficiently infected by retroviruses. (A) Schematic
diagram of retroviral vectors used in this study. The MSCV LTR drives the
expression of the enhanced Gfp downstream of an IRES in the control vector,
MiGfp. The cre recombinase is cloned upstream of the IRES GFP cassette and
also is driven by the MSCV LTR, MCiGfp. MCS, multiple cloning site. (B)
Fluorescence-activated cell sorting analysis measuring Gfp expression of the
Abelson line Dnmtcond1 infected with either MiGfp or MCiGfp at 2 days
postinfection gated on live cells by scatter properties. (C) Measurement of the
percentage of live Gfp1 cells as a function of time postinfection either infected
with MiGfp or MCiGfp as labeled. Each line represents an independent
experiment.
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(MiGfp). The experimental retrovirus had the cre recombinase
gene cloned into the MCS generating a bicistronic vector
(MCiGfp). This allowed us to monitor, and purify, by fluores-
cence-activated cell sorting the infected (Gfp1) and uninfected
(Gfp2) populations of cells. In addition, given the bicistronic
nature of the vector, we could be confident that the Gfp1 cells
that were infected by the MCiGfp retrovirus also expressed the
cre recombinase. Using a 1-h spin infection of retroviral super-
natant generated by cotransfecting 293 cells with either the
MiGfp or the MCiGfp vector and a replication incompetent
helper plasmid, pCL-eco (29), we reproducibly infected over
70% of the cells as measured by flow cytometry (Fig. 1B).
We then assayed the viability of the cells after infection. At 2
days postinfection, we observed a similar percentage of Gfp1
viable cells that had been infected with either MiGfp or MCiGfp
(Fig. 1 B and C). In contrast, by 4 days postinfection, when the
cells had undergone two rounds of cell division, the number of
Gfp1 cells that were infected with MCiGfp had declined whereas
the number of Gfp1 cells infected with MiGfp remained stable
(Fig. 1C). This finding suggests that the loss in viability of the
cells might be caused by reduced genomic DNA methylation as
a result of deletion of the Dnmt1 locus. This possibility is
consistent with previous observations that mice deficient for
Dnmt1 die early in embryogenesis (28) and mouse embryonic
fibroblasts in which Dnmt1 is deleted are not viable (C.B.,
unpublished observation).
Cre-Mediated Loss of DNMT1. We verified that cells infected by
MCiGfp had indeed deleted their Dnmt1 locus via cre-mediated
recombination. Taking advantage of the incomplete infection of
each cell line, we analyzed infected (Gfp1) cells separately from
uninfected (Gfp2) cells that were either infected with MiGfp or
MCiGfp (Fig. 1B, see gates). We purified these cells by fluo-
rescence-activated cell sorting and performed Southern blot
analysis on the genomic DNA from these purified populations.
A schematic diagram of the Dnmt1 locus before and after
cre-mediated recombination is shown in Fig. 2A. Southern blot
analysis demonstrated that only the cells that were infected by
MCiGfp and were Gfp1 had deleted their Dnmt1 locus by day
2 postinfection (Fig. 2B, lanes 3 and 8). Additionally, there was
no recombination either in cells that were not infected by a
cre-containing retrovirus (MiGfp) or had not been infected
(Gfp2) (Fig. 2B). Over time there was an accumulation of cells
that were Gfp1 but had not excised their Dnmt1 locus as seen by
the presence of the 2lox band in lane 10. However, this represents
less than 10% of the total cells in this fraction.
Methylation Status of the Kappa Locus. We next determined the
methylation status of the Dnmtcond lines under the different
conditions to access the efficiency of demethylation caused by
the loss of the Dnmt1 gene. Because of the mechanism of action
of the maintenance methyltransferase Dnmt1, two rounds of
replication are required to generate an unmethylated genome;
after one cell division both daughter cells are hemimethylated,
and after the second round, two daughters are unmethylated and
two daughters are hemimethylated. The original methylated
parental strands of DNA are not lost, but simply diluted in the
population as the cells divide. To assess whether this was
apparent in the excised Dnmtcond lines we treated genomic DNA
with the methylation-sensitive restriction enzyme HhaI to assay
the methylation status of the Jk region of the kappa locus. We
assayed this region of the kappa locus as it has been shown to be
demethylated in a developmentally regulated manner that tightly
correlates with the recombination potential of the region (30). A
schematic diagram of the locus is shown along with the restric-
tion sites (H) and the probe used for analysis (Fig. 3A).
Dnmt12/2 embryonic stem (ES) cell DNA was used as a control
for unmethylated genomic DNA (Fig. 3B, lane 13).
The kappa locus of the untreated Abelson lines is fully
methylated as seen by the lack of digestion of the genomic DNA
by HhaI (Fig. 3B, lane 9). This was expected because the
efficiency of recombination at the kappa locus is low. In contrast,
cells that had been infected by MCiGfp 4 days earlier and were
Gfp1 had a substantial level of unmethylated DNA (Fig. 3B,
lanes 4 and 8). Genomic DNA from cells that had only been
infected for 2 days or that were infected by MiGfp remained
methylated (Fig. 3B, lanes 1 and 5). This is consistent with
excision of the Dnmt1 gene by day 2 postinfection followed by
two rounds of cell division causing the loss of DNA methylation
by day 4 postinfection. The absolute level of hypomethylation is
less than in cells null for the Dnmt1 locus but significant; more
than 30% of the alleles are unmethylated.
We also evaluated the methylation status of IAPs because they
are normally highly methylated retrotransposons present in
hundreds of copies in the genome (31) and thus a sensitive
readout for alterations of genomewide DNA methylation state.
We digested genomic DNA with HpaII, another methylation-
sensitive restriction enzyme that digests the IAP sequences a
number of times, generating a diagnostic ladder of bands. Again,
we used Dnmt1 null ES cell DNA as a control for unmethylated
DNA (Fig. 3C, lane 2). Southern blot analysis demonstrated that
the IAP sequences were highly methylated in Abelson lines (Fig.
3C, lanes 3–6). As expected, these sequences were hypomethy-
lated in cells that were Gfp1 and were infected by MCiGfp at
least 4 days earlier (Fig. 3C, lane 7). This correlates with the loss
of methylation observed at the kappa locus. Once again, there is
no effect on the methylation status of the IAP sequences if cells
were infected by MiGfp, were Gfp2, or were only 2 days
postinfection (Fig. 3C, data not shown).
Fig. 2. Abelson lines infected with MCiGfp efficiently excise the Dnmt1 locus.
(A) Schematic diagram of the genomic Dnmt1 locus. The genotype of the
Abelson lines are 2loxyN before cre-mediated excision. WT, wild type. (B)
Southern blot analysis of the Dnmt1 locus from purified populations of
infected Dnmtcond Abelson lines infected with either MiGfp or MCiGfp and
sorted for Gfp1 viable cells (G1 or CiG1, respectively). The DNA was digested
with SpeI and probed with a fragment from the Dnmt1 locus. The bands are
labeled on the right.









Activation of Transcription of the Kappa Locus by Demethylation. It
has been demonstrated that there is a tight correlation between
the transcriptional status of the antigen receptor loci and their
ability to be recombined. Transcription of various Ig genes is
activated concomitant with their rearrangement (7, 32, 33).
Specifically, within the kappa locus the synthesis of a transcript
that encompasses the Jk gene segments, k0, can be detected upon
induction of kappa rearrangement (Fig. 4A; ref. 27). Addition-
ally, hypermethylation has been associated with transcriptional
silencing, and changes in methylation can alter gene expression
(10). Therefore, we determined whether loss of methylation in
our Abelson lines affected the expression of k0. We used a
RT-PCR Southern assay on total genomic RNA randomly
primed and amplified by using the primers k0 and Ck and
detected by using the probe Jk2 (26) shown schematically in Fig.
4A. LPS treatment of our Abelson lines activated transcription
of k0 (Fig. 4 B and C, compare lanes 1 and 2). In addition,
retroviral infection increased the basal level of k0, but it re-
mained inducible by LPS treatment (compare lanes 1 and 4 in
Fig. 4 B and C).
In this assay the two independent Abelson lines behaved
differently. Loss of methylation of Dnmtcond1 cells did not result
in an increase in ko expression. Gfp1 cells infected with MCiGfp
had a similar level of ko compared with cells that were infected
with MiGfp at day 5 postinfection. In contrast, at day 5 postin-
fection Dnmtcond2 cells that were infected with MCiGfp and
were Gfp1 expressed significantly more k0 as compared with
Gfp1 cells infected with MiGfp. Therefore, in Dnmtcond2 cells
the loss of methylation results in the activation of k0 expression,
suggesting that the loss of methylation can activate transcription
of the kappa locus under some conditions. In addition, hypo-
methylation is not a prerequisite for transcription because
LPS-treated cultures that induce transcription of k0 have no
detectable change in the methylation status of the kappa locus
(Fig. 3B, compare lanes 9 and 10).
Recombination of the Kappa Locus. Once we generated Abelson
lines that had demethylated their kappa locus, we wanted to
Fig. 3. Loss of Dnmt1 results in the loss of genomic methylation by day 4
postinfection. (A) Schematic diagram of the murine kappa locus. The map
shows the V and J gene segments, constant region (Ck) and the intronic
enhancer (Ek). The methylation-sensitive restrictions sites, HhaI (H), are shown
as well as the probe used for analysis (Jk). The diagram is not to scale. (B)
Southern blot analysis of the methylation status of the kappa locus in Abelson
lines under different conditions. The DNA was digested with HhaI and probed
with a Jk probe that spans the J region of the kappa locus. Lanes 1–8 are
derived from Gfp1 sorted Abelson lines infected with the MiGfp (G) or MCiGfp
(CG) at the time points indicated postinfection. Lanes 9–12 are generated
from unsorted bulk populations of cells. Lane 9, untreated; lane 10, treated
with LPS; lane 11, treated with butyrate; lane 12 treated with HC toxin. Lane
13 is derived from untreated Dnmt2/2 ES cells. (C) Southern blot analysis of the
methylation status of IAPs in Abelson lines. The DNA was digested with HpaII
and probed with a fragment of a known, endogenous IAP. Lanes 1 and 2 are
controls, derived from ES cells that are wild type or mutant for the Dnmt1
locus, respectively. Lanes 3–7 are derived from Gfp1 or Gfp2 sorted Dnmtcond1
Abelson line infected with either MiGfp (G) or MCiGfp (CG) at the time points
indicated. The unmethylated fragments are shown on the right.
Fig. 4. Loss of methylation at the kappa locus activates transcription in
Dnmtcond2. (A) Schematic diagram of the murine kappa locus. The large arrow
designates the promoter of the ko transcript. The primers ko and Ck used for
PCR and the Jk2 primer used as a probe to detect the ko product are shown
schematically. (B) RT-PCR analysis of the expression level of ko in the Dnmtcond1
line under different conditions. Lanes 1–3 are unsorted cells either untreated
(lane 1), or treated with LPS (lane 2) or HC toxin (lane 3) for 24 h. Lanes 4–7 are
derived from cells 5 days postinfection. The cells were either infected with
MiGfp (G) or MCiGfp (CG). Lanes 4 and 5 are unsorted infected cells, and lanes
6 and 7 are Gfp1 sorted cells. Lane 8 is the product of an RT-PCR with no RNA
template. Lane 9 is the product of a PCR assay with no DNA template. (C)
RT-PCR analysis of expression of ko in the Dnmtcond2 line under different
conditions. Lanes 1–3 are unsorted cells either untreated (lane 1), or treated
with LPS (lane 2) or HC toxin (lane 3) for 24 h. Lanes 4 and 5 are derived from
cells sorted for Gfp expression 5 days postinfection either infected with MiGfp
(G) or MCiGfp (CG). Lane 6 is the product of a PCR assay with no DNA template.
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determine the effect on the recombination efficiency of the
kappa locus. We used a PCR-Southern assay that specifically
amplifies the rearranged alleles by using primers Jk2 and Vk (Fig.
5A; ref. 27). Our Abelson lines have a similarly low level of
recombination at the kappa locus as other previously assayed
Abelson lines such as line 230–238 (Fig. 5C, compare lanes 1 and
5). The level of recombination has been estimated at 0.01%–
0.001% and hypermethylation of the locus is thought to be
responsible for this repression. Interestingly, we found that the
Gfp1 cells infected with both the experimental and control
retrovirus had an increased level of recombination as compared
with their Gfp2 counterparts (Fig. 5B, compare lanes 1 and 2).
Nevertheless, when we compared Gfp1 cells that were either
infected with MiGfp or MCiGfp, either at 2 days or 4 or 5 days
postinfection, we could detect no difference in the efficiency of
recombination at the kappa locus (Fig. 5B, compare lanes 2 and
4 and lanes 6 and 8). This demonstrates that demethylation of the
kappa locus is not sufficient to activate recombination.
To verify that the V(D)J recombination of the kappa locus of
the Dnmtcond Abelson lines was inducible under previously
described conditions we treated them with LPS. Indeed, we
found that both Dnmtcond lines had an increased level of
recombination 24 h post-LPS treatment (Fig. 5C, compare lanes
3 and 4; data not shown) that was similar to the level of induction
measured in the 230–238 Abelson line (Fig. 5C, lanes 1 and 2;
ref. 27). We also treated the infected cultures with LPS at day 5
postinfection and found that we were able to increase the level
of recombination to similar extents whether the cells were
infected with MiGfp or MCiGfp (data not shown). This finding
demonstrates that the demethylated cells were recombination-
ally active and activatable given the appropriate stimulus.
In addition, we verified that the cells expressed the V(D)J
recombinase, Rag-1 and Rag-2, using the same cDNA as gener-
ated for the ko transcription assay. RT-PCR demonstrated that
the expression levels of both genes were unaffected by retroviral
infection with either MiGfp or MCiGfp at all time points (data
not shown).
Discussion
The regulation of V(D)J recombination must be very complex to
ensure the functional assembly of only one antigen receptor gene
per cell and to avoid unnecessary double-stranded breaks in the
process. To accomplish this, V(D)J recombination is controlled
at many levels. Changes in the accessibility of target sites
mediated by demethylation has been long thought to be one of
the major strategies used to regulate the specificity of the
recombination process. Two opposing hypotheses can account
for the correlation between the activation of transcription and
demethylation with recombinational activity. The first is that
there is a causal relationship between recombination and tran-
scriptionyhypomethylation. In this case, changes in methylation
andyor transcription would directly alter the chromatin structure
of target sites, thus allowing the recombinase access to previ-
ously silent loci. An alternate hypothesis is that specific changes
in chromatin, mediated by trans-acting factors, allow the recom-
bination machinery access to target sites. This change also may
be permissive for transcription andyor demethylation, resulting
in the simultaneous but coincidental change in these properties.
Our results support the second model, which posits that specific
factors are required to change the chromatin structure of target
sites, allowing the recombinase access to the DNA.
Using our assay system we determined whether a hyper-
methylated and transcriptionally inactive kappa locus can be-
come accessible simply by demethylating the locus. We reasoned
that if DNA methylation was the rate-limiting step controlling
accessibility and specificity of the recombination process, then
the loss of methylation should allow the recombination machin-
ery access to those sequences, and an increase in recombination
at the kappa locus should be detectable. We found that the loss
of methylation at the kappa locus did not significantly affect the
efficiency of V(D)J recombination. In contrast, we found that
hypomethylation activated expression of the kappa locus in one
line, Dnmtcond2. This transcriptional activation was comparable
to LPS-mediated activation at the kappa locus and demonstrates
that hypermethylation is at least in part responsible for tran-
scriptional repression. The finding that LPS can activate tran-
scription without generally affecting the methylation status
suggests that multiple pathways exist to activate the ko promoter.
Distinct mechanistic pathways to activate the ko promoter have
been demonstrated by the differential requirements for NF-kB
in LPS- and interferon-mediated induction of the promoter in
Abelson lines (27).
In contrast to demethylation, LPS treatment activated recom-
bination of the kappa locus in these lines (27). These two findings
at first seem contradictory: both LPS and hypomethylation can
lead to transcription of the locus, yet, only LPS treatment
activates recombination. These data can be explained by the
requirement for specific factors to alter the accessibility of the
target sites for the recombination machinery, at least one of
which can be induced by LPS, resulting in these properties being
regulated independently. Therefore, demethylation of the kappa
locus is not the regulatory mechanism used by the cell to control
the specificity of locus choice. Moreover, that LPS activates
Fig. 5. V(D)J recombination of the kappa locus is unaffected by loss of
methylation. (A) Schematic diagram of the murine kappa locus. The degen-
erate primer Vk is homologous to many members of the Vk gene segment
families and is used with the primer Jk2. These primers can only amplify a
product once V(D)J recombination has brought the gene segments into close
proximity. The product is detected by Southern blot analysis of the PCR
products probed with the primer Jk1. (B) PCR-Southern analysis of genomic
DNA from Dnmtcond2 infected with either MiGfp or MCiGfp and sorted at the
labeled time points postinfection. The cells were sorted for both Gfp1 and
Gfp2 populations and assayed as described in A. (C) PCR-Southern blot of
genomic DNA from unsorted Dnmtcond1 or the Abelson line 230–238 previ-
ously demonstrated to respond to LPS treatment. The cells were either un-
treated (lanes 1 and 3) or treated with LPS for 24 h (lanes 2 and lane 4). Lane
5 is a 5-fold dilution of the genomic DNA in lane 4 and amplified in parallel.









recombination in the absence of detectable demethylation sug-
gests that demethylation may be irrelevant to the recombination
process. Nevertheless, other processes must exist to control
target site selection for the V(D)J recombinase.
Previous studies using exogenous substrates and genetically
modified endogenous loci largely demonstrated a direct rela-
tionship between transcription, hypomethylation, and recombi-
nation, leading to the suggestion that changes in these properties
were required for recombination. However, these studies were
unable to directly modulate transcription or methylation but
instead relied on alterations of the substrate and subsequent
analysis of transcription, methylation, and recombination. Some
substrates did have discordant effects on these properties;
whereas some substrates were transcriptionally active but re-
combinationally silent (34, 35), others were transcriptionally
silent but recombinationally active (36). Additionally, a geneti-
cally modified heavy chain locus was developmentally demeth-
ylated but recombinationally silent (37). Therefore, transcription
and demethylation per se are not simply permissive for rear-
rangement, but specific enhancer sequences and cognate binding
factors must be critical. This supports our findings at the kappa
locus. Moreover, recent studies using an episomal recombination
substrate demonstrated that the repression of recombination by
methylation could be overcome, at least in part, by changes in
chromatin structure, suggesting a role for specific factors in
remodeling chromatin for recombination (37).
Because demethylation was not sufficient for the activation of
recombination at the kappa locus, other factors, acting indepen-
dently of methylation, must exist to alter the accessibility of the
kappa locus for recombination. Recent data suggests that nu-
cleosomal remodeling may be the critical change required to
allow the V(D)J recombinase access to target sites (15, 38, 39).
The role of demethylation may be to alter the chromatin
structure of the kappa locus, providing a permanent change in
the accessibility of the locus for transcription. This locus must
remain transcriptionally active for the lifespan of the B cell
because loss of expression in a mature lymphocyte leads to
apoptosis (40). Methylation also may serve a negative role by
repressing the basal level of recombination throughout the loci
and cryptic genomic sites. Previous studies have demonstrated
that methylated recombination substrates are less recombina-
tionally active (15–17). Further studies are required to isolate the
factors that confer specificity to the recombination process and
to determine the mechanism by which they alter the accessibility
of loci for recombination.
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